Form 4: Expensify CEO Sells 30,000 Shares Under 10b5-1 Plan

Expensify CEO David Michael Barrett sold 30,000 shares of Class A Common Stock for a weighted average price of $1.92 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Chief Executive Officer and Director David Michael Barrett disposed of 30,000 shares of Expensify, Inc. Class A Common Stock.
• The transaction occurred on September 2, 2025, at a weighted average price of $1.92 per share, with prices ranging from $1.91 to $1.94.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Barrett on March 31, 2025.
• Following the reported transaction, Mr. Barrett directly beneficially owns 210,676 shares and indirectly beneficially owns 1,468,480 shares through Barrett Trust LLC.

Sentiment

Score: 4

Explanation: The sale of shares by the CEO, even under a 10b5-1 plan, can be perceived negatively by the market, especially given the relatively low share price. However, the pre-planned nature mitigates some of the immediate negative implications, preventing a lower score.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating the sale was not based on new, non-public information and was scheduled in advance.

Negatives

• Chief Executive Officer David Michael Barrett disposed of 30,000 shares of Class A Common Stock.
• The sale price of $1.92 per share is relatively low, which could be perceived negatively by investors.

Future Outlook

N/A

Industry Context

N/A

Related Party Transactions

• Indirect beneficial ownership of 1,468,480 shares is held through Barrett Trust LLC, a manager-managed limited liability company where the Reporting Person is the manager and trustee for the controlling member, the Barrett Family Trust.

Stakeholder Impact

• Shareholders may interpret the insider sale as a negative signal, potentially impacting investor confidence and the company's stock price.

Key Dates

Recommendation

The sale of shares by the CEO, while a negative signal, was conducted under a pre-arranged 10b5-1 plan, suggesting it was not based on new, material non-public information. This mitigates the immediate negative impact, but investors should monitor future insider activity and company performance. A 'hold' recommendation is appropriate as this single transaction does not fundamentally alter the investment thesis, but it warrants caution.

Keywords

Expensify, EXFY, insider trading, Form 4, stock sale, CEO, David Michael Barrett, 10b5-1 plan